Ginkgo Bioworks has been bolstering its position as a first mover in Synthetic Biology!

 . Here are the companies they’ve acquired and the reasons behind each acquisition:

1. Proof Diagnostics:

   -  Ginkgo Bioworks acquired Proof Diagnostics, a Cambridge-based CRISPR test developer co-founded by Feng Zhang (an early discoverer of Crispr technology) of the Broad Institute of MIT and Harvard. 
2. Proof Diagnostics has been working on a “future-proof” COVID-19 screener with a rapid tabletop analyzer capable of detecting not only COVID-19 but also the flu, respiratory syncytial virus, and other diseases using gene-editing technology. 
3. Ginkgo was mainly attracted to Proof Diagnostics for its intellectual property and libraries of RNA-programmable, non-Cas enzymes called OMEGAs. These emerging OMEGAs offer potential upgrades over current genomic medicine tools, making them easier to deliver into cells. Ginkgo plans to use these enzymes to support its gene therapy services, providing an alternative approach to gene editing.

4. Patch Biosciences: - Ginkgo acquired Patch Biosciences, a New York-based AI platform developer focused on computer-designed cargos for genetic medicines. By integrating Patch’s capabilities, libraries, and datasets, Ginkgo aims to enhance its existing genetic medicine toolkit. 

   The machine-learning models and downstream assays from Patch Biosciences will contribute to Ginkgo’s offerings.

5. Reverie Labs:

    - Ginkgo also acquired Reverie Labs, an AI-powered drug discovery company. Reverie Labs specializes in developing biology-focused foundation models and small molecule design. Four members of Reverie’s AI team, including Chief Technology Officer Ankit Gupta, have joined Ginkgo. 

   This acquisition will accelerate Ginkgo’s work in drug discovery and strengthen its expertise in biological engineering approaches.

Additionally, it’s worth noting that Ginkgo Bioworks made its largest acquisition to date by acquiring it's competitor, Zymergen, which is expected to significantly enhance Ginkgo’s platform by integrating strong automation and software capabilities. 

These acquisitions demonstrate Ginkgo’s commitment to advancing synthetic biology and expanding its capabilities in molecular medicine and AI-driven research. 

 Ginkgo Bioworks is an American biotech company founded in 2008 by five scientists from MIT, led by Jason Kelly. 

Their specialty lies in using genetic engineering to produce bacteria with industrial applications for other biotech companies. 

Essentially, they create custom-designed microorganisms that can be used in various fields, from agriculture to pharmaceuticals.

By doing so, they help other companies skip the costly initial stages of designing synthetic biology products. 

Their cell programming platform enables the growth of biotechnology across diverse markets, including food, fragrance, and pharmaceuticals

Ginkgo Bioworks Holdings (NYSE: DNA) is owned by 57.35% institutional shareholders, 13.56% by insiders, and 29.08% retail investors.

Article:

3 Reasons Why Cathie Wood Is Buying Ginkgo Bioworks Stock Hand Over Fist | The Motley Fool

KEY POINTS from this article:

• 
  
• 1.   The biofoundry's platform is scaling up, "big time" and customers are flocking.
• 2.
•        

  Powerful collaborators are signing up

  It's working with Merck, Moderna, Eli Lilly, and many others in biopharma and agriculture.

• 3  Ginkgo's valuation is attractive, and trading as a penny stock at all time lows!

Disclosure: we own stock in Ginkgo Bioworks ($DNA) and are accumulating!

Analysts high on Ginkgo and it's platform.

StockScan estimates an average price of $6.06 for Ginkgo Bioworks in 2025, with predictions ranging from a low of $4.78 to a high of $7.34​ (Stock Screener, Chart, and Price) This indicates a potential rise of approximately 980.45% from the last recorded price. While Ginkgo faces challenges, its long-term opportunities in #CellProgramming and #Biosecurity could drive significant growth. Keep in mind that investing involves risks, and it’s essential to conduct thorough research before making any investment decisions

I asked ChatGPT, What a merger between Twist Biosciences and Ginkgo Bioworks might do for the growth of Synthetic Biology!

"The rapid and complete resolution of aggressive MSS colorectal cancer tumors observed in this study is unprecedented in the field" says the author Dr. Kasi

IBC Advanced Alloys Signs MOU with Global Nuclear Fuels America and Ceramic Tubular Products to Advance Nuclear Fuel Initiatives

IBC Advanced Alloys Corp.

TSX VENTURE : IB
OTCQX : IAALF

October 31, 2013 09:30 ET

IBC to explore opportunities with GNF-A and CTP to advance accident tolerant nuclear fuel technologies

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Oct. 31, 2013) - IBC Advanced Alloys Corp. (TSX VENTURE:IB)(OTCQX:IAALF) ("IBC" or the "Company") is pleased to announce that it has signed a memorandum of understanding (the "MOU") with Global Nuclear Fuel - Americas, LLC ("GNF-A") and Ceramic Tubular Products, LLC ("CTP") to explore opportunities to collaborate on nuclear fuel research. The MOU was signed following meetings at the recent American Nuclear Society's annual Top Fuels conference where IBC presented recent R&D developments on its beryllium oxide ("BeO") nuclear fuel focused on developing a safer and more accident tolerant nuclear fuel.

Under the terms of the agreement, the parties will enter into discussions regarding a potential joint collaborative effort to develop and analyze the benefits of increased cooperation and interaction regarding the development and commercialization of the advanced beryllium oxide-silicon carbide ("BeO-SiC") fuel technology. The parties have also agreed to explore available opportunities for government or industry partner funding for accident tolerant fuel R&D initiatives.

Based in Wilmington, N.C., GNF-A is a joint venture of General Electric, Hitachi Ltd. and Toshiba Corporation and is a leading fabricator and supplier of Boiling Water Reactors ("BWR") fuel and services. GNF-A strives to continually advance fuel technologies to meet the demands of today's power reactors and to support a strong nuclear industry.

CTP, based in Rockville, MD is developing advanced silicon carbide nuclear fuel cladding which will improve both industry economics and safety. CTP has been awarded multiple grants, including one from the US Department of Energy, to further research, identify and evaluate complementary fuel forms, such as IBC's BeO enhanced fuel.

IBC recently reported that the Massachusetts Institute of Technology ("MIT") completed a fuel performance study supporting IBC's BeO nuclear fuel technology combined with CTP's silicon carbide cladding. The MIT report validates how IBC's BeO enhanced fuel and CTP's SiC cladding could reduce fuel operating temperatures and improve fuel operating characteristics leading to a safer and more accident tolerant fuel. The report, along with other recent findings from Texas A&M and Purdue Universities, was presented at the Top Fuels conference.

"We are very pleased to have signed this MOU with IBC and CTP which could have significant fuel cycle benefits for plant operators," said Chet Akiri, COO of GNF-A. "The potential benefits of the improved thermal conductivity fuel, combined with CTP's cladding technology, include lower fuel operating temperatures that deliver the same energy to the reactor system. GNF is committed," continued Akiri, "to pursuing new technologies that will improve fuel performance and result in important benefits for our utility customers."

Herb Feinroth, CEO of Ceramic Tubular Products, echoed Akiri's sentiments and said, "The tests of CTP's TRIPLEX Silicon Carbide cladding have already shown the potential for hundreds of times lower heat release and hydrogen release during severe accidents as compared to the current metal cladding now used in commercial reactors. The combination of CTP's cladding technology with IBC's enhanced BeO fuel," continued Feinroth, "could mark a significant step in the development of more accident tolerant nuclear fuels and we look forward to working with IBC and GNF to advance this important initiative."
As a result of recent nuclear industry events, industry officials and governments are supporting alternative advanced fuel designs including increased R&D initiatives for more accident tolerant fuels. Because of this increasing industry awareness the parties to the agreement look forward to entering into discussions with a number of potential nuclear industry partners to explore and discuss the next phase of R&D including irradiation requirements and testing of the fuel in test reactors.

About IBC Advanced Alloys Corp.
IBC is an integrated manufacturer and distributor of rare metals (beryllium) based alloys and related products serving a variety of sectors including aerospace, automotive, telecommunications and a range of industrial applications. IBC has 83 employees and production facilities in Indiana, Massachusetts, Pennsylvania and Missouri. IBC is creating a dynamic global advanced alloys company. IBC's common shares are traded on the TSX Venture Exchange under the symbol "IB" and the OTCQX under the symbol "IAALF".
This news release was prepared by management of IBC, which takes full responsibility for its contents. The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy of this news release. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This disclosure contains certain forward-looking statements that involve substantial known and unknown risks and uncertainties, certain of which are beyond the Company's control including: the impact of general economic conditions in the areas in which the Company operates, industry conditions, changes in laws and regulations including the adoption of new environmental laws and regulations and changes in how they are interpreted and enforced, increased competition, the lack of availability of qualified personnel or management, limited availability of raw materials, fluctuations in commodity prices, foreign exchange or interest rates, stock market volatility and obtaining required approvals of regulatory authorities. In addition there are risks and uncertainties associated with manufacturing activities therefore the Company's future results, performance or achievements could differ materially from those expressed in these forward-looking statements. All statements included in this press release that address activities, events or developments that the Company expects, believes or anticipates will or may occur in the future are forward-looking statements. These statements are based on assumptions made by the Company based on its experience, perception of historical trends, current conditions, expected future developments and other factors it believes are appropriate in the circumstances.

Contact Information

• 
  
  IBC Advanced Alloys Corp.
  Ian Tootill, Director of Corporate Communications
  (604) 685-6263 ext. 110
  itootill@ibcadvancedalloys.com
  www.ibcadvancedalloys.com

MIT performance report supports Beryllium Nuclear Fuel and SiC fuel technology

Published Tuesday, July 9, 2013 6:05 am

VANCOUVER, BC – July 9^th, 2013 – IBC Advanced Alloys Corp. (TSX-V: IB; OTCQX: IAALF) (“IBC” or the “Company”) reports that the Massachusetts Institute of Technology (“MIT”) has completed its initial review and delivered a fuel performance report validating the feasibility of IBC’s patented beryllium oxide (“BeO”) nuclear fuel technology combined with Ceramic Tubular Products, LLC (“CTP”) silicon carbide cladding. As reported in June 2012, IBC entered into a sponsored research agreement with MIT to analyze the performance of the BeO enhanced fuel and how it would perform with the addition of silicon carbide ("SiC) cladding.

IBC’s partnerships with CTP and MIT regarding a SiC based ceramic composite cladding complement IBC’s ongoing nuclear fuel R&D being conducted at Purdue and Texas A&M universities. The fuel performance report validates the characteristics of the fuel technology and further demonstrates how IBC’s BeO enhanced fuel, combined with CTP’s SiC cladding, could result in reduced fuel operating temperature and improve fuel operating characteristics leading to a safer and more accident tolerant fuel.

As a result of recent events in the nuclear industry, especially the well known issues at Fukushima in 2011, industry officials and governments are developing alternative strategies and increasingly reviewing the safety benefits of accident tolerant fuels. Because of this increasing industry awareness, the Company is in discussions with a number of potential nuclear industry partners, including Japanese fuel cycle suppliers, to explore and discuss the next phase of R&D including irradiation requirements and testing of the fuel in test reactors.

“We are very encouraged with the conclusions of the MIT fuel performance report about the beneficial characteristics and capability of the enhanced BeO fuel in combination with the SiC cladding technology”, said Jim Malone, IBC’s Vice President of Nuclear Fuel. “IBC is working diligently with Purdue, Texas A&M, CTP and and other industry participants to take the next step of a full irradiation trial in a test reactor to further understand and evaluate the advantages of BeO enhanced fuel as a next generation accident tolerant fuel.”

The IBC sponsored research at MIT is led by Dr. Mujid Kazimi, the MIT Tokyo Electric Power Company (“TEPCO”) Professor in Nuclear Engineering. Dr. Kazimi is also an MIT Professor of Mechanical Engineering and the Director of the Center for Advanced Nuclear Energy Systems (“CANES”). Dr. Kazimi is an expert on fuel performance, safety and power density with a substantial body of peer-reviewed publications as well as numerous academic awards and nuclear industry honors. In addition to his MIT responsibilities, Dr. Kazimi is also a member of the Nuclear Energy Advisory Committee at the US Department of Energy.

As previously reported, IBC has extended its research agreements with Purdue and Texas A&M, to advance its BeO nuclear fuels R&D until December 2013. IBC’s nuclear fuel program is focused on developing an accident tolerant high thermal conductivity BeO nuclear fuel for both current and future nuclear power reactors that is more efficient and safer than existing nuclear fuels. The project’s objective is to commercialize the intellectual property and to position IBC as an essential part of the nuclear industry’s supply chain.

About IBC Advanced Alloys Corp.

IBC is an integrated manufacturer and distributor of rare metals (beryllium) based alloys and related products serving a variety of sectors including aerospace, automotive, telecommunications and a range of industrial applications. IBC has 86 employees and production facilities in Indiana, Massachusetts, Pennsylvania and Missouri. IBC is creating a dynamic global advanced alloys company. IBC’s common shares are traded on the TSX Venture Exchange under the symbol “IB” and the OTCQX under the symbol “IAALF”.

IBC Advanced Alloys Corp.

Ian Tootill, Director of Corporate Communications

(604) 685-6263 ext 110

Email: itootill@ibcadvancedalloys.com

Website: www.ibcadvancedalloys.com